abstract |
A solid oral pharmaceutical composition comprising tenofovir or a pharmaceutically acceptable salt thereof, emtricitabine or a pharmaceutically acceptable salt thereof, and lactose monohydrate and microcrystalline cellulose as diluents, wherein lactose monohydrate is in an amount of from 10 to 15% by weight of the composition, and the composition is substantially free of starch. |